Study finds no significant survival benefit from participating in cancer clinical trials

FHS
May 23, 2024
8:19 pm

Participation in cancer clinical trials often suggests improved survival rates, but high-quality studies accounting for biases show no significant survival benefit. Trial benefits may be overstated due to confounding factors.

Sanofi pours €1.3B into new insulin manufacturing plant in Frankfurt

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 2, 2024

AbbVie’s full year 2023 sees 6.4% net revenue drop

Share this article The immunology portfolio of AbbVie, which faced stiff competition from Humira biosimilars, saw revenues decrease by 9.6% to $26.14bn. Credit: Valery Zankovych

February 5, 2024

FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction

Finerenone reduced heart failure (HF) events and cardiovascular death in patients with HF and mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF), according to late-breaking

September 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.